Hepatitis C and Alternative Medicine News
http://feeds.blogsieve.com/676
Wine and Liver Health (Hepatitis Central)
Although a study emerging from San Diego claims that a small amount of wine may protect the liver, the researchers admit that this is not true for those already living with liver disease. In fact, there are several more caveats...
What You Must Know About Alcoholic Hepatitis (Hepatitis Central)
If you think one must be a heavy drinker to suffer from this condition, you ought to read this article. Discover the causes, risk factors and complications of alcoholic hepatitis. Share this information with others. After reading this, anyone with...
Purer, Less Costly Interferon for Hepatitis C and B Treatment (Hepatitis Central)
The Taiwan-based biopharmaceutical company PharmaEssentia Corp. is testing P1101, its third-generation PEG-interferon-alpha drug candidate. Because it is a longer-lasting, purer interferon that is less costly to produce, P1101 could enhance the treatment options for Hepatitis C and B....
Optimism Swells After Liver Conference (Hepatitis Central)
Several researchers at the May 2008 Digestive Disease Week in San Diego reported encouraging progress in their mission to extinguish liver disease. One of the advancements announced includes monitoring dendritic cells to determine which Hepatitis C patients will fare well...
New Technology May Help Treat Hepatitis (Hepatitis Central)
While pharmaceutical companies are racing to find safer, more effective treatments for viral Hepatitis C and B, physicists from Arizona have a unique perspective on accomplishing the same goal. Learn how these scientists believe the virus could be rendered harmelss...
New Mexico Offers Free Hepatitis C Hotline (Hepatitis Central)
Finally being recognized as the widespread, public health problem that it is, the New Mexico Department of Health has taken a giant step forward to help people with Hepatitis C. By launching a new, toll-free phone number, locals concerned about...
Marijuana Use Sparks Liver Transplant Controversy (Hepatitis Central)
Despite its legality in 12 states, learn why medical marijuana use may render a person with Hepatitis C ineligible for a liver transplant....
HCV Viral Load Reduced in Phase I/II Trial (Hepatitis Central)
Given to those already infected with Hepatitis C, ChronVac-C® is designed to boost the immune response against the virus. Preliminary trial results report a decrease in viral load of over 95 percent in the first patient to complete ChronVac-C® therapy....
HCV Treatment Success: Early Response vs. Genotype (Hepatitis Central)
As presented at the April 2008 meeting of the European Association for the Study of the Liver, a rapid virological response can help clinicians customize the length of treatment for Hepatitis C ? regardless of genotype....
HCV Cure Associated with Early Drop in Viral Load (Hepatitis Central)
Australian researchers find that the suppression of Hepatitis C viral load within the first month of beginning treatment is a good predictor of defeating the virus - regardless of co-infection with HIV....
Good News for Non-Responders to HCV Combination Therapy (Hepatitis Central)
A Phase 3 trial evaluating ZADAXIN® (thymalfasin) as a potential third component for Hepatitis C traditional combination therapy has just been completed. Although the data is currently being analyzed and won't be available until later in the year, the lead...
Fatty Liver Disease is a Major Health Concern (Hepatitis Central)
This liver disorder is incredibly common and its progression to a serious disease is usually preventable....
15 Tips for Managing Interferon-Ribavirin Side Effects (Hepatitis Central)
Many people abandon this challenging HCV treatment mid-course. Here are 15 ways to help manage the side effects of Hepatitis C combination therapy, to help patients' likelihood of completing the extremely challenging treatment. Share this article among patients contemplating and/or...
time to stop and smell the roses - Irish Independent (alternative medicine - Google News )
time to stop and smell the roses
Irish Independent, Ireland - 1 hour ago
She firmly believes her frenetic lifestyle had been the catalyst for her illness and that alternative medicine was the answer. "I think stress caused my ...
Yoga as Bunion Buster? - Washington Post (alternative medicine - Google News )
Yoga as Bunion Buster?
Washington Post, United States - 1 hour ago
It's just the kind of issue that exists in that intriguing interface between mainstream medicine and alternative practices -- where prejudices on both sides ...
Vancomycin-Resistant Enterococci (VRE) (MedicineNet Infectious Disease General)
Title: Vancomycin-Resistant Enterococci (VRE)
Category: Diseases and Conditions
Created: 5/8/2007
Last Editorial Review: 5/29/2008
Steno 'Superbug' Genome Shows Extreme Drug Resistance (MedicineNet Infectious Disease General)
Title: Steno 'Superbug' Genome Shows Extreme Drug Resistance
Category: Health News
Created: 5/10/2008 2:00:00 AM
Last Editorial Review: 5/12/2008
Silver-Coated Endotracheal Tubes Cut Down on Infections (MedicineNet Infectious Disease General)
Title: Silver-Coated Endotracheal Tubes Cut Down on Infections
Category: Health News
Created: 5/20/2008 2:00:00 AM
Last Editorial Review: 5/20/2008
Scientists ID Enzyme That Allows Dysentery Amoeba to Hide (MedicineNet Infectious Disease General)
Title: Scientists ID Enzyme That Allows Dysentery Amoeba to Hide
Category: Health News
Created: 6/20/2008 2:00:00 AM
Last Editorial Review: 6/20/2008
Physician and Patient Attitudes towards Complementary and ... ...
Physician and Patient Attitudes towards Complementary and ...
7thSpace Interactive (press release), NY - Jun 26, 2008
In the US, complementary and alternative medicine (CAM) use is most prevalent among reproductive age, educated women. We sought to determine general ...
New Breakthrough Could Prevent Hepatitis C Replication (Hepatitis Central)
Inspired by a pharmaceutical prototype to stop bovine viral diarrhea virus, Immtech reveals that one of their compounds may inhibit Hepatitis C's entry into human cells....
MRSA Rates Tied to Hospital Understaffing (MedicineNet Infectious Disease General)
Title: MRSA Rates Tied to Hospital Understaffing
Category: Health News
Created: 6/25/2008 2:00:00 AM
Last Editorial Review: 6/25/2008
MRSA Infections Can Bug Fitness Buffs (MedicineNet Infectious Disease General)
Title: MRSA Infections Can Bug Fitness Buffs
Category: Health News
Created: 7/3/2008 2:00:00 AM
Last Editorial Review: 7/3/2008
International Conference in Holguín Promotes Natural Alternative ... ...
International Conference in Holguín Promotes Natural Alternative ...
Radio Nuevitas, Cuba - Jun 26, 2008
Sixty academia studies are to be presented at the conference, which takes place near a flagship alternative medicine hospital in Holguín. ...
Germicidal Wipes Can Spread Bacteria (MedicineNet Infectious Disease General)
Title: Germicidal Wipes Can Spread Bacteria
Category: Health News
Created: 6/4/2008
Last Editorial Review: 6/4/2008
GP training to include the fringe alternatives - The Age (alternative medicine - Google News )
GP training to include the fringe alternatives
The Age, Australia - Jul 4, 2008
But the college says alternative medicine is growing in popularity, and doctors should be able to give reliable advice on these therapies. ...
Doctors in for a dose of alternative medicine - The Age (alternative medicine - Google News )
Doctors in for a dose of alternative medicine
The Age, Australia - Jul 4, 2008
It gives me a sense that I'm in the right place, somewhere between alternative medicine and Western," he told an interviewer. ...
Complementary medicine: seeking out alternatives - Telegraph.co. ...
Telegraph.co.ukComplementary medicine: seeking out alternatives
Telegraph.co.uk, United Kingdom - Jun 10, 2008
Alternative therapists now outnumber GPs in the UK, universities run courses on alternative medicine and the industry receives £500 million a year from the ...
Alternative therapies put to the test Telegraph.co.uk
all 2 news articles
Communication Key to Blending Eastern and Western Medicine - RedOrbit (alternative medicine - ...
Communication Key to Blending Eastern and Western Medicine
RedOrbit, TX - Jun 30, 2008
Yet alternative medicine is finding its place in health care. "There are some things that Western medicine just can't fix," Evans said. ...
C. diff Epidemic: What You Must Know (MedicineNet Infectious Disease General)
Title: C. diff Epidemic: What You Must Know
Category: Health News
Created: 6/2/2008
Last Editorial Review: 6/2/2008
Bug Off: Improved Repellents Beat DEET (MedicineNet Infectious Disease General)
Title: Bug Off: Improved Repellents Beat DEET
Category: Health News
Created: 5/28/2008
Last Editorial Review: 5/28/2008
Bug Bites and Stings (MedicineNet Infectious Disease General)
Title: Bug Bites and Stings
Category: Diseases and Conditions
Created: 6/19/2008
Last Editorial Review: 6/19/2008
Antibiotic Resistance (Drug Resistance, Antimicrobial Resistance) (MedicineNet Infectious ...
Title: Antibiotic Resistance (Drug Resistance, Antimicrobial Resistance)
Category: Diseases and Conditions
Created: 11/12/2004
Last Editorial Review: 5/29/2008
Alternative therapies up close - The Gazette (Montreal) (alternative medicine - Google News )
The Gazette (Montreal)Alternative therapies up close
The Gazette (Montreal), Canada - 21 hours ago
In Trick or Treatment, British authors Simon Singh and Edzard Ernst expose the false claims and profiteering of alternative medicine while sounding the ...
Alternative Medicine Solutions Markets Naringenin, Grapefruit ... - NewsReleaseWire. ...
NewsReleaseWire.com (press release)Alternative Medicine Solutions Markets Naringenin, Grapefruit ...
NewsReleaseWire.com (press release) - Jun 24, 2008
Lloyd Wright, CEO of AMS Inc. and author of ?Triumph Over Hepatitis C: An Alternative Medicine Solution,? is currently the only one in the world marketing a ...
Alcoholism and Viral Hepatitis (Hepatitis Central)
Conquering viral hepatitis is hard enough without the added challenge of alcoholism. The drug gabapentin as a treatment for alcohol dependence is currently being evaluated in human trials....
Abdominal Pain (MedicineNet Infectious Disease General)
Title: Abdominal Pain
Category: Diseases and Conditions
Created: 12/31/1997
Last Editorial Review: 7/1/2008
Expert Recap: Focus on Investigational HCV Agents (Clinical Care Options Hepatitis - HCV )
Ira M. Jacobson, MD, discusses the latest data on novel agents for the treatment of chronic hepatitis C.
Telaprevir Resistance Mutations Emerge Among Hepatitis C Patients Who Relapse Following ...
Telaprevir resistance mutations detected following 2 weeks of telaprevir-based therapy and standard peginterferon alfa-2a/ribavirin therapy
Significant Proportion of HCV/HIV-Coinfected Patients Refuse HCV Therapy in Large German ...
HCV/HIV-coinfected patients often decline anti-HCV therapy despite tolerability and efficacy of peginterferon alfa-2a plus ribavirin
Short Duration VCH-759 Demonstrates Potent Antiviral Activity in HCV Genotype 1a and 1b ...
Novel HCV NS5B polymerase inhibitor, VCH-759, shown to be safe and effective in genotype 1a and 1b patients during short-term study.
Robust Response to Peginterferon alfa-2b Plus Ribavirin Among HCV-Infected IV Drug Users on ...
HCV-infected IV drug users undergoing opioid maintenance therapy achieve response rates similar to patients not undergoing opioid therapy when adjusted for age, HCV genotype, and baseline HCV RNA level.
R7128, Promising Therapy for HCV Genotype 1 Nonresponders, Demonstrates Potent Antiviral ...
R7128 shown to be well tolerated with significant viral suppression and no viral rebound in HCV genotype 1-infected nonresponders over 14 days.
Peginterferon/Ribavirin/Nitazoxanide Increases Sustained Virologic Response Rate in ...
Study suggests potential SVR benefit to interferon-experienced patients with addition of nitazoxanide to standard-of-care peginterferon alfa-2a and ribavirin in genotype 4 HCV patients
PROVE2 Study Shows High SVR Rates With Combination Treatment With Telaprevir, Peginterferon ...
Telaprevir in combination with peginterferon alfa-2a plus ribavirin demonstrates strong virologic suppression with minimal adverse events.
PROVE 1 Study: Combination Telaprevir, Peginterferon alfa-2a, and Ribavirin Therapy Has Rapid ...
Telaprevir in combination with peginterferon alfa-2a and ribavirin results in high SVR rates treatment-naive HCV genotype 1 patients but is associated with increased incidence of dermatologic and gastrointestinal adverse events.
Multiple Infusions of Bavituximab Safe and Active Against HCV (Clinical Care Options ...
Bavituximab administered twice weekly for 2 weeks in HCV patients appears safe and well tolerated at doses up to 6 mg/kg
HCV Polymerase Inhibitor R1626 Has High Genetic Barrier to Resistance With Potent Antiviral ...
R1626 with or without peginterferon alfa-2a and ribavirin potently suppresses viral replication in patients chronically infected with HCV genotype 1
HCV Polymerase Inhibitor R1626 Combined With PegIFN/RBV Results in greater than 80% of HCV ...
High dosages of R1626 produce robust antiviral effects but are associated with high rates of cytopenias and gastrointestinal adverse events in HCV genotype 1 patients.
HCV FibroSURE and FIBROSpect II Comparable for Fibrosis Staging in Chronic Hepatitis C ...
Serodiagnostic marker panel tests FibroSURE and FIBROSpect II have similar positive and negative predictive abilities for staging METAVIR F2-F4 fibrosis.
GI-5005, a Yeast-Based Immunotherapy, Results in Dose-Dependent HCV-Specific Cellular Immune ...
Novel immunotherapy, GI-5005, results strong immune response, and some antiviral activity in chronic hepatitis C patients.
Favorable HCV, HBV Outcomes in HCV/HBV-Coinfected Patients Treated With Peginterferon alfa-2a ...
Peginterferon alfa-2a plus ribavirin therapy resulted in similar rates of HCV clearance when compared with HCV-monoinfected patients and led to HBsAg clearance in a significant proportion of patients at end-of-treatment follow-up
Expert Analysis: Update on Investigational Agents in HCV: 2007 (Clinical Care Options ...
Nezam H. Afdhal, MD, FRCPI, Ira M. Jacobson, MD, and David R. Nelson, MD review data from the meeting in Boston.
Exper Recap: Update on Investigational Agents in HCV: 2007 (Clinical Care Options Hepatitis - ...
Watch and listen as Ira M. Jacobson, MD, reviews key data on investigational HCV agents presented at the 2007 Boston liver disease meeting.
Development of Model for End-Stage Liver Disease Improved Graft and Overall Survival Rates ...
3-year graft and survival rates following liver transplant in HCC patients with and without HCV infection improved after development of MELD
Case: Management of a 38-Year-Old Male on Methadone Maintenance Therapy Who Presents With PCP ...
William G. Powderly, MD, discusses selection of initial therapy for a 38-year-old recovering IDU male with HIV/HCV coinfection who presents with PCP.
Biweekly Administration of Controlled-Release Recombinant Interferon alfa-2b Appears to Be ...
Phase IIa study of controlled-release recombinant interferon alfa-2b demonstrates potent antiviral activity and is well tolerated among HCV genotype 1-infected, treatment-naive patients
Albinterferon alfa-2b Achieves SVR in Some Hepatitis C Patients Who Failed Previous ...
Significant antiviral activity of higher doses of albinterferon alfa-2b in previous interferon/ribavirin HCV nonresponders may not translate into higher SVR rates.
Advances in HCV Management Strategies With Approved Agents (Clinical Care Options Hepatitis - ...
Raymond T. Chung, MD, Mitchell L. Shiffman, MD, and Mark S. Sulkowski, MD review new data from the meeting in Boston.
28 Days of Telaprevir, Peginterferon alfa-2a, and Ribavirin Followed by 44 Weeks of ...
Telaprevir shown to be safe and effective during combination treatment with peginterferon alfa-2a plus ribavirin among a small cohort of mostly minority patients.